drugset / Trial / NCT00174538
Codeine in Sickle Cell Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective of this study is to determine if a subject's genetic make-up would affect the treatment response to codeine in subjects with sickle cell disease.
Timeline
- Start
- 2005-03
- Primary completion
- —
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Codeine | Small molecule | 30 mg | Oral |